A pathogenic bovine histophilic strain HSX-25051 and its application

By providing the bovine histophilic bacteria strain HSX-25051 carrying the luxS gene, the problem of the scarcity of bovine strain resources has been solved, stable growth and clear pathogenicity have been achieved, a standardized pathogenic research system has been established, and research on prevention and control technologies for bovine respiratory disease syndrome has been promoted.

CN123063312APending Publication Date: 2026-11-10INNER MONGOLIA AGRICULTURAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611350651.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-02
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Existing technologies present challenges in isolating bovine histophilic bacteria, which exhibit poor passage stability and a scarcity of pathogenic strains. This makes it difficult to establish a standardized pathogen research system and vaccine candidate strains, thus limiting research on prevention and control technologies for bovine respiratory disease syndrome.

Method used

We provide a bovine histophilic bacteria strain HSX-25051 carrying the luxS gene, which has a clear pathogenicity. Through systematic identification and whole-genome sequencing, we ensured that it grows stably on a specific culture medium and exhibits clear pathogenic characteristics in animal models, providing a standardized strain for pathogenicity research and vaccine development.

Benefits of technology

The use of this strain solves the problem of scarce bovine sleep histophilia resources, provides a reliable basis for etiological research, can construct stable animal infection models for detection, pathogenic mechanism research and vaccine development, and improves the research efficiency and effectiveness of prevention and control technologies.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123063312A_ABST
    Figure CN123063312A_ABST
Patent Text Reader

Abstract

This invention provides a pathogenic bovine Histophila dormantis strain HSX-25051 and its applications, belonging to the fields of veterinary microbiology and biotechnology. This invention obtained a bovine Histophila dormantis strain HSX-25051 isolated from the lungs of a diseased calf, with a clearly defined origin, and completed systematic classification, identification, and preservation. This strain exhibits strong host invasion ability and clear pathogenicity. These characteristics enable this strain to be used as a standard challenge strain for constructing stable and reproducible animal models of bovine Histophila dormantis infection, overcoming the experimental fluctuations caused by unclear strain virulence and background in existing models. It solves the problem of scarce resources of prevalent bovine Histophila dormantis strains in China and the lack of standardized reference strains with systematically identified biological characteristics, providing a reliable bacterial strain basis for pathogen epidemiological investigations, molecular diagnostic reagent development, animal infection model construction, and prevention and control technology research.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the fields of veterinary microbiology and biotechnology, and in particular to a pathogenic bovine histophilic bacteria strain HSX-25051 and its applications. Background Technology

[0002] Sleeping histophilia ( Histophilus somni, H. somni *Bacillus cereus* is a Gram-negative, pleomorphic coccus belonging to the Pasteurella family. It is a common opportunistic pathogen affecting the respiratory mucosa and urogenital tract of cattle. This bacterium, alone or in synergy with bovine respiratory syncytial virus, *Pasteurella multocida*, and hemolytic *Mannsella hyopneumoniae*, can cause Bovine Respiratory Disease Complex (BRDC). Clinical manifestations include acute septicemia, fibrinous purulent bronchopneumonia, meningitis, myocarditis, arthritis, scrotal dermatitis, and reproductive disorders in cows. It is one of the important bacterial pathogens causing sudden death, increased culling rates, and decreased feed efficiency in large-scale beef and dairy cattle farming.

[0003] because H. somni It has demanding nutritional requirements, needing to grow slowly in a culture medium rich in serum or heme and under microaerophilic conditions of 5%–10% CO2. Its colonies are small and easily destroyed by Mansonia. 、 The bacteria inhibit faster-growing BRDC pathogens such as Pasteurella. Therefore, direct isolation and culture from clinical samples is effective. H. somni The success rate is low, and the passage stability is poor; many positive samples still cannot be pure cultured even after multiple generations of streaking. Meanwhile, different sources... H. somni The strains exhibit significant differences in genomic composition, virulence factor profiles (such as IbpA, oligosaccharides, and biofilm formation ability), and animal pathogenicity, with blurred boundaries between pathogenic strains and mucosal symbiotic strains. This dual characteristic of "difficult isolation + strong heterogeneity" has long limited basic research on this pathogen and the development of control products.

[0004] At the level of pathogenic mechanisms and infection models, mouse intraperitoneal infection and calf intranasal / tracheal inoculation models require strains with reproducible virulence and a clearly defined MLD (minimum lethal dose); however, bovine strains are not commonly found in published literature. H. somni The isolated strains are very limited, with only sporadic reports of isolation in Yunnan, Inner Mongolia and other places. Moreover, most of them have not been systematically evaluated for morphology, biochemistry, drug sensitivity, whole genome, growth curves and cross-immunoprotection, making them difficult to serve as "benchmark strains" for cross-institutional comparison.

[0005] At the level of vaccines and biological products, the screening of candidate strains for inactivated vaccines and subunit vaccines also takes "passage stability + high bacterial density + clear pathogenicity + good immunogenicity" as the core threshold. However, there is almost no existing domestic circulating strains that meet the above conditions, which restricts the determination of candidate antigens for vaccines and the establishment of seed batches for production.

[0006] In summary, obtaining a bovine Histophilus hibernation strain with a clear origin, reliable identification, and distinct biological characteristics and pathogenicity is of significant scientific research value and practical application for establishing a pathogen research system, conducting research on infection mechanisms, constructing animal infection models, and evaluating relevant prevention and control measures. Summary of the Invention

[0007] The purpose of this invention is to provide a pathogenic bovine Histophila dormica strain HSX-25051 and its applications, wherein the HSX-25051 strain carries a virulence gene associated with the pathogenicity of Histophila dormica (… luxS It contains no non-pathogenic pHS129 plasmid characteristic genes and has significant pathogenicity, providing a standardized strain for etiological research, pathogenic mechanism analysis and animal pathogenic model construction of related diseases.

[0008] To achieve the above-mentioned objectives, the present invention provides the following technical solution: This invention provides a pathogenic bovine histophila (Bacillus hygrophila) strain. Histophilus somni, H. somni HSX-25051, this strain is deposited at the China General Microbiological Culture Collection Center (CGMCC) on June 23, 2026, with accession number CGMCC No. 39378, at the Institute of Microbiology, Chinese Academy of Sciences, No. 3, No. 1 Beichen West Road, Chaoyang District, Beijing.

[0009] Furthermore, the *Histophilus nocturnalis* HSX-25051 carries pathogenicity associated with *Histophilus nocturnalis*. luxS Gene.

[0010] Furthermore, the aforementioned Histophilus slumberae HSX-25051 can cause one or more clinical manifestations, including depression, somnolence, and abnormal breathing, as well as histopathological changes in one or more organs, including the lungs, spleen, and liver.

[0011] The present invention also provides an application of the above-mentioned histophilic bacteria HSX-25051 in etiological research.

[0012] Furthermore, the etiological studies include the construction of bovine Histoplasma sleep infection animal models, research on the pathogenic mechanism of Histoplasma sleep, or research on the host infection process.

[0013] The beneficial effects of this invention compared to the prior art are as follows: (1) This invention obtained a bovine histophila hyaline strain HSX-25051 isolated from the lungs of a diseased calf with a clear origin, and completed systematic classification, identification and preservation. This strain solves the problem of scarce resources of popular bovine histophila hyaline strains in China and the lack of standardized reference strains identified by systematic biological characteristics, providing a reliable bacterial material basis for pathogen epidemiological investigation, molecular diagnostic reagent development, animal infection model construction and prevention and control technology research.

[0014] (2) This invention elucidates in detail the growth characteristics of strain HSX-25051 on a specific culture medium (brain and heart extract medium containing 5% sterile defibrinated sheep blood), and describes its typical colony morphology (transparent edges, grayish-white center, round, moist and glossy, 1-2 mm in diameter). This culture method and phenotypic characteristics are beneficial for the stable passage of this strain in subsequent studies, the standardized preparation of bacterial counts, and the replication and comparison of experimental results between different laboratories.

[0015] (3) This invention confirms, through molecular detection and whole-genome sequencing, that strain HSX-25051 carries pathogenicity-related pathogens. luxS The strain possesses quorum sensing genes and does not contain non-pathogenic pHS129 plasmid characteristic genes. Further genomic analysis revealed the presence of genes related to lipo-oligosaccharide (LOS) synthesis, host adhesion, iron acquisition, and multiple potential genomic islands (including genes related to outer membrane structure formation, environmental adaptation, and mobile genetic elements), all crucial genetic elements associated with host adaptation and infection processes. The identification of these genetic characteristics reveals the pathogenic potential of this strain at the molecular level, providing precise genetic information for subsequent analysis of the pathogenic mechanism of *Histopsomnia solani*, screening of drug targets, and vaccine candidate antigens.

[0016] (4) This invention has demonstrated through animal infection experiments that HSX-25051 strain can induce typical clinical symptoms such as depression and abnormal breathing in mice after intraperitoneal infection, and can lead to tissue lesions and bacterial colonization in parenchymal organs such as the lungs, spleen, and liver, proving that it has a strong host invasion ability and clear pathogenicity. This characteristic enables this strain to be used as a standard challenge strain to construct a stable and reproducible animal model of bovine Histoplasma hibernation infection, overcoming the experimental fluctuation problem caused by unclear virulence and background of existing models.

[0017] (5) The HSX-25051 strain provided by this invention can be widely used in the etiological detection of bovine histophilia (e.g., as a qPCR positive control), pathogenic mechanism research (e.g., gene knockout to verify the function of virulence factors), screening of novel antimicrobial drugs, and as a candidate strain for inactivated or subunit vaccines. This strain provides a complete set of standardized biological materials and evaluation tools for the research on prevention and control technologies of bovine respiratory disease syndrome (BRDC).

[0018] The bovine hibernating histophilic bacterium HSX-25051 of the present invention was isolated from a lung sample of a calf and deposited on June 23, 2026, at the China General Microbiological Culture Collection Center (CGMCC) with accession number CGMCC No. 39378. The deposit address is Institute of Microbiology, Chinese Academy of Sciences, No. 3, No. 1 Beichen West Road, Chaoyang District, Beijing. Attached Figure Description

[0019] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0020] Figure 1 The colony morphology of bovine hibernating histophilic bacteria strain HSX-25051 on 5% sterile defibrinated sheep blood BHI solid culture medium in Example 1 of this invention; Figure 2 The growth curve of strain HSX-25051 in Example 1 of this invention; Figure 3 The results of morphological identification of strain HSX-25051 in Example 1 of this invention are shown, where A is Wright staining and B is Gram staining. Figure 4 The results of colony-specific qPCR for strain HSX-25051 in Example 1 of this invention are shown, where 1 and 2 are single colonies picked from 5% sterile defibrinated sheep blood BHI solid medium, and 3 is the negative control. Figure 5 The results of PCR for 16S rRNA of strain HSX-25051 in Example 1 of this invention are shown, where M is DL 2000 DNA marker, 1 is negative control, 2 is positive control, and 3 is the target fragment of the 16S rRNA gene of strain HSX-25051. Figure 6 The results of homology comparison of the 16S rRNA gene sequence of strain HSX-25051 in Example 1 of this invention; Figure 7 The results of virulence and non-virulence gene detection of HSX-25051 strain in Example 2 of this invention are shown, where M is a 500bp DNA Marker, 1 is a negative control, and 2, 3, and 4 are HSX-25051 strains. luxS Genetic testing results: 5, 6, and 7 are the pHS129 gene detection results of strain HSX-25051. Figure 8The images show the necropsy changes of mice injected intraperitoneally with HSX-25051 strain in Example 3 of this invention. 1 represents the control group, 2 represents the challenge group, A represents the peritoneal cavity of dead mice in the challenge group, B represents the lungs of mice, C represents the spleen of mice, and D represents the liver of mice. Figure 9 The survival curves of mice injected intraperitoneally with HSX-25051 strain in Example 3 of this invention are shown. Figure 10 The results of qPCR on tissues from mice after intraperitoneal injection of HSX-25051 strain in Example 3 of this invention are shown below. 1: Spleen of the challenge group; 2: Liver of the challenge group; 3: Kidney of the challenge group; 4: Lung of the challenge group; 5: Negative control. Figure 11 The bacterial load in organs of different challenge dose groups of HSX-25051 strain in Example 3 of this invention is shown, where A: challenge dose is 2×10 11 CFU / mL, B: Challenge dose is 2×10 10 CFU / mL, C: Challenge dose is 2×10⁻⁶ 9 CFU / mL, D: Challenge dose is 2×10⁻⁶ 8 CFU / mL; Figure 12 This is a circled genome diagram of the HSX-25051 strain CGView in Example 4 of the present invention; Figure 13 This is a linear map of the genome islands of strain HSX-25051 in Example 4 of the present invention. Detailed Implementation

[0021] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as a limitation of the present invention, but rather as a more detailed description of certain aspects, features, and embodiments of the present invention.

[0022] It should be understood that the terminology used in this invention is merely for describing particular embodiments and is not intended to limit the invention. Furthermore, with respect to numerical ranges in this invention, it should be understood that each intermediate value between the upper and lower limits of the range is also specifically disclosed. Every smaller range between any stated value or intermediate value within a stated range, and any other stated value or intermediate value within said range, is also included in this invention. The upper and lower limits of these smaller ranges may be independently included or excluded from the range.

[0023] Unless otherwise stated, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. While only preferred methods and materials have been described herein, any methods and materials similar or equivalent to those described herein may be used in the implementation or testing of this invention. All references to this specification are incorporated by way of citation to disclose and describe methods and / or materials associated with those references. In the event of any conflict with any incorporated reference, the content of this specification shall prevail.

[0024] Various modifications and variations can be made to the specific embodiments described in this specification without departing from the scope or spirit of the invention, as will be apparent to those skilled in the art. Other embodiments derived from this specification will also be apparent to those skilled in the art. This specification and embodiments are merely exemplary.

[0025] The terms “include,” “including,” “have,” “contain,” etc., used in this article are all open-ended terms, meaning that they include but are not limited to.

[0026] Example 1 Example 1 of this invention provides a method for culturing and identifying bovine histophilic bacteria strain HSX-25051, the specific steps of which are as follows: 1.1 Strain Isolation a. Sample pretreatment: Take lung tissue samples from diseased calves and place them in a pre-cooled mortar. Add liquid nitrogen and grind them thoroughly. Collect the samples into a 1.5 mL centrifuge tube, add 1 mL of pre-cooled PBS buffer, centrifuge briefly, collect the supernatant, and store at 4°C for later use.

[0027] b. Isolation of the strain: The supernatant was inoculated into brain and heart extract broth solid medium (supplemented with 5% sterile defibrinated sheep blood) and incubated upside down at 37℃ and 5% CO2 for 24–48 h. The results are as follows: Figure 1 As shown, colonies with translucent edges, grayish-white centers, and round, moist, and glossy surfaces can be observed on the culture medium. The colony diameter is 1–2 mm. Select colonies that meet the criteria… H. somni Typical colony morphology, continuously passaged.

[0028] c. Plotting the growth curve: Inoculate a single colony into 5 mL of brain and heart extract broth (supplemented with 5% fetal bovine serum), and incubate at 37°C and 200 rpm. Adjust the bacterial concentration to 10... 6CFU / mL, cultured at 37℃ and 200 rpm for 24 h. OD600 was measured at 200 μL of bacterial culture at 0 h, 2 h, 4 h, 6 h, 8 h, 10 h, 12 h, 14 h, 16 h, 18 h, 20 h, 22 h, and 24 h, with three replicates for each measurement. 100 μL of bacterial culture was serially diluted 10-fold. -3 ~10 -7 Gradual dilutions were evenly spread on brain and heart extract broth solid medium (supplemented with 5% sterile defibrinated sheep blood) and incubated at 37°C and 5% CO2 for 24 h. Each dilution was replicated in triplicate. After incubation, the colony counts on each plate were counted, and plates with colony counts between 30 and 300 were selected for statistical analysis to calculate the number of viable bacteria per milliliter of culture. Results are as follows: Figure 2 As shown in the figure. The results indicate that strain HSX-25051 was in a lag phase from 0 to 2 h, a logarithmic growth phase from 2 to 12 h, entered a stationary growth phase from 12 to 20 h, and gradually entered the decline phase after 22 h.

[0029] 1.2 Strain Identification a. Morphological identification: Single colonies were picked and subjected to Wright's staining and Gram staining. Results are as follows: Figure 3 As shown. After Wright staining, the bacterial cells are blue-purple, short rod-shaped or coccobacillus-shaped, with intense staining at both poles, and can be arranged singly or in pairs. Some cells are arranged in short chains or filaments. Figure 3 (A); After Gram staining, the bacteria appear pink, a typical characteristic of Gram-negative bacteria. The isolates are bipolar, deeply stained cocci with blunt, rounded ends, arranged singly or in pairs. Figure 3 (B)

[0030] b. PCR detection: Single colonies were picked and placed in 200 μL of physiological saline. Bacterial DNA was extracted and qPCR was performed. Primers and amplification procedures were prepared and amplified according to the patent "Quantitative Real-Time PCR Detection Kit for Bovine Sleeping Histophilia and its Dedicated Primers and TaqMan Probes". Results are as follows: Figure 4 As shown, the Ct values ​​of the selected single colonies were 30.28 and 31.12, respectively; simultaneously, 16S rRNA amplification and product sequencing were performed and compared, with the results as follows. Figure 5 , Figure 6 As shown, consistent with the expected results, strain HSX-25051 is... H. somni .

[0031] Example 2 Example 2 of this invention conducted virulence gene detection on strain HSX-25051. The specific steps are as follows: Using extracted bacterial DNA as a template, H. somni Virulence factor LOS geneluxS and non-pathogenic H. somni The 129pt plasmid gene pHS129 was amplified by PCR to determine its virulence. Primers, reaction system, and procedure are shown in Tables 1-4. Results are as follows: Figure 7 As shown, luxS The gene fragment size was 117 bp, and the results showed a clear band between 100 bp and 150 bp. No band of the non-pathogenic gene pHS129 with a size of 172 bp was found between 150 bp and 200 bp.

[0032] Table 1 luxS and pHS129 gene primer sequence

[0033] Table 2 luxS PCR reaction system with pHS129

[0034] Table 3 luxS PCR reaction procedure

[0035] Table 4 pHS129 PCR reaction procedure

[0036] Example 3 Example 3 of this invention conducted a pathogenicity test on strain HSX-25051, and the specific steps are as follows: 3.1 Mouse challenge test HSX-25051 strain was cultured to the logarithmic growth phase, and the bacterial concentration was adjusted for intraperitoneal injection. SPF-grade KM mice were randomly divided into 6 groups of 6 mice each (grouping shown in Table 5). Mice were observed for 10 days after challenge, weighed regularly, and their clinical manifestations and the number of dead mice were recorded. Dead mice were aseptically dissected to observe organ lesions. Mice that received intraperitoneal injection showed clinical signs such as depression, decreased appetite, huddling, and lethargy within 1 hour; after 6 hours, they exhibited rapid breathing, tremors, and increased eye discharge; after 8 hours, groups 1 and 2 died successively, while mice in group 6 showed no obvious abnormalities. The results of the dissection of challenged mice are as follows: Figure 8 As shown, pathological changes in multiple organs are visible, with hemorrhages in the lungs, enlargement and congestion in the spleen, and a blunt, rounded, enlarged liver. No obvious lesions were found in the remaining tissues.

[0037] Table 5. Grouping and Dosage of Bovine Histophila Sleeping in Mice for Pathogenicity Test

[0038] 3.2 Determination of LD50 and plotting of survival curves The number of dead mice was counted using the formula lg LD. 50 = Xm d(∑Pi 0.5) (Xm: logarithmic value of the highest dose group; d: logarithmic interval between adjacent dose groups; ∑Pi: sum of mortality rates of each dose group) combined LD50 (CFU / animal) = LD 50 The median lethal dose (LD50) was calculated using (CFU / mL) × V (mL). The results are shown in Table 6 and... Figure 9 As shown, the LD50 of strain HSX-25051 50 It is 1.86×10 8 CFU / mouse. There were significant differences in the time and number of deaths among mice in different dose groups. As the challenge dose decreased, the time to death prolonged while the mortality rate decreased. All mice in groups 1 and 2 died within 24 hours. The mortality rate in group 3 reached 67% within 24 hours, and the mortality rate in group 4 was 17% within 24 hours. No deaths occurred in groups 5 and 6 during the observation period.

[0039] Table 6 LD of HSX-25051 strain 50 Measurement

[0040] 3.3 Bacterial Detection in Organs and Tissues qPCR and bacterial load were performed on tissues and organs of mice in the challenge group. Spleen, liver, kidney, and lung tissues from dead mice in the challenge group were collected for qPCR detection, and bacterial load was detected in all tissues. H. somni The result is as follows Figure 10 As shown, the Ct values ​​of the spleen, liver, kidney, and lungs of the challenged mice were 26.58, 26.84, 27.24, and 31.25, respectively. The bacterial load in the tissues was detected using the method described in Example 1.1, and the results are as follows. Figure 11 As shown, a one-way ANOVA was performed on the bacterial load in different organs under the same challenge dose. The results were: Group 1: F=42.60; Group 2: F=65.58; Group 3: F=57.20; Group 4: F=30.73. The results showed that there were certain differences in bacterial colonization among the tissues.

[0041] Example 4 Example 4 of this invention describes the whole-genome sequencing and functional annotation analysis of strain HSX-25051. The specific steps are as follows: 4.1 Whole genome sequencing of HSX-25051 strain DNA was extracted from strain HSX-25051, and whole-genome sequencing was performed using a high-throughput sequencing platform. The raw sequencing data underwent quality control to remove low-quality sequences and adapter contamination sequences. Sequence assembly software was then used to assemble the sequences, obtaining the complete genome sequence of strain HSX-25051. The results are shown in Table 7 and... Figure 12 As shown, the genome of strain HSX-25051 consists of one circular chromosome and one plasmid, with a total genome length of 2,167,204 bp and a GC content of 37.3%. A total of 1,942 protein-coding genes (CDS), 16 rRNA genes, 47 tRNA genes, and 22 ncRNA genes were predicted. At the same time, one DNA transposition-related sequence was found, indicating that strain HSX-25051 has a complete bacterial genome structure and a stable genetic basis.

[0042] Table 7 Genome assembly data of HSX-25051 strain

[0043] 4.2 Analysis of virulence-related genes in strain HSX-25051 To analyze the potential pathogenicity-related genetic characteristics of strain HSX-25051, the predicted whole-genome protein sequences of strain HSX-25051 were compared with those in the VFDB (Virulence Factor Database). Candidate genes related to bacterial virulence were selected based on sequence similarity, coverage, and statistical significance. The results are shown in Table 8. Strain HSX-25051 carries multiple functional genes related to the bacterial infection process, mainly involved in host adhesion, outer membrane formation, iron acquisition, immune regulation, environmental adaptation, and bacterial survival. Specifically, regarding outer membrane formation and host immune interaction, strain HSX-25051 was found to carry multiple genes related to lipo-oligosaccharide (LOS) synthesis and modification, including… lpxA, lpxB, lpxC, kdtA, rfaD and rfaF Since LOS is an important component of the outer membrane of Gram-negative bacteria and is closely related to bacterial outer membrane stability, host immune recognition, and the induction of inflammatory responses, the above genetic characteristics suggest that strain HSX-25051 has a genetic basis for participating in host immune interactions and infection establishment.

[0044] Table 8. Functional classification of virulence-related genes in strain HSX-25051

[0045] Further analysis revealed (Table 9) that strain HSX-25051 carries multiple functional genes closely related to the infection process of *Histoplasma sleeper*. Genes were detected in regions related to lipooligosaccharide (LOS) synthesis and outer membrane structure formation. lpxA, lpxB, lpxC, kdtA, rfaD as well as rfaF These genes are involved in the formation of outer membrane lipid A and core oligosaccharide structures in Gram-negative bacteria, and are related to bacterial outer membrane stability, host immune recognition, and the regulation of inflammatory responses during infection. In functional analyses related to host adhesion and colonization, strain HSX-25051 was found to carry t... apC, oapA as well as hia / hsf Related genes. The proteins encoded by these genes are involved in bacterial surface structure formation and host cell adhesion, suggesting that strain HSX-25051 has a genetic basis for promoting host tissue colonization. Iron acquisition-related functional analysis detected... hmbR , chuW as well as fur Isogenes. Among them hmbR Participates in the binding and transport of heme. chuW It participates in metabolic processes related to heme utilization. fur These genes are involved in the regulation of iron homeostasis. The above genes suggest that the HSX-25051 strain can utilize iron sources within the host to maintain growth and adapt to infection.

[0046] Table 9. Major virulence-related genetic markers of strain HSX-25051

[0047] 4.3 Analysis of pathogen-pathogen interaction-related genes in HSX-25051 strain To further analyze the potential genetic basis of HSX-25051 strain's involvement in the host infection process, its whole genome sequence was compared with the PHI (Pathogen-Host Interaction Database). The results showed that the HSX-25051 strain genome contains multiple homologous genes related to pathogen-host interaction, including genes related to quorum sensing regulation, outer membrane structure formation, oxidative stress response, and host adaptation. luxS Genes related to quorum sensing, lipo-oligosaccharide synthesis, and stress adaptation were all detected. These results indicate that strain HSX-25051 possesses the genetic basis for involvement in host environmental adaptation, bacterial quorum regulation, and infection process maintenance.

[0048] Combined with the HSX-25051 strain in Example 2 of this invention luxSThe positive result, along with the absence of the characteristic gene of the non-pathogenic reference strain pHS129 plasmid, further demonstrates that this strain possesses genetic characteristics associated with pathogenicity.

[0049] 4.4 Genomic island analysis of HSX-25051 strain To analyze specific genetic regions in the genome of strain HSX-25051, genome island prediction software was used to predict its complete genome sequence. The results are shown in Table 10. Nine potential genome island regions (GI01-GI09) were predicted in the HSX-25051 genome, containing a total of 148 predicted genes. These genome island regions contain genes of various functional types, including membrane structure-related proteins, lipooligosaccharide assembly-related proteins, toxin-antitoxin system-related proteins, phage-related proteins, and transposon-related proteins.

[0050] Table 10 Major virulence-related genetic markers of strain HSX-25051

[0051] Further analysis revealed that ( Figure 13 The HSX-25051 strain contains genomic island regions that encode LapB / LapA-related proteins, as well as genetic elements such as phage tail structural proteins, phage assembly proteins, and VgrG / Pvc8 family proteins. Among these, Lap-related proteins may be involved in maintaining the bacterial outer membrane structure, while phage-related regions and mobile genetic elements may influence bacterial genome plasticity and environmental adaptability. The HSX-25051 strain possesses unique genomic regions containing multiple functional genes, providing a potential genetic basis for its survival within the host, adaptation to environmental changes, and maintenance of the infection process. 4.5 Comprehensive analysis of the genetic characteristics of strain HSX-25051 Based on the results of whole-genome sequencing, virulence gene prediction, pathogen-pathogen interaction analysis, and genome island analysis, the bovine-derived Histoplasma hirsutum strain HSX-25051 possesses a complete genome structure and carries multiple genetic elements related to the pathogenic process, including luxS Quorum sensing genes, LOS synthesis-related genes, host adhesion-related genes, iron acquisition-related genes, and multiple functional genomic island regions.

[0052] The above-mentioned genetic characteristics are consistent with the results of strain identification, virulence testing, and animal infection experiments described above. After infecting animals, the HSX-25051 strain can induce obvious clinical symptoms and colonize multiple tissues and organs, demonstrating strong host adaptability and pathogenic potential.

[0053] The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.

Claims

1. A pathogenic bovine histophila strain ( Histophilus somni HSX-25051, this strain is deposited at the China General Microbiological Culture Collection Center (CGMCC) on June 23, 2026, with accession number CGMCC No. 39378, at the Institute of Microbiology, Chinese Academy of Sciences, No. 3, No. 1 Beichen West Road, Chaoyang District, Beijing.

2. The *Histophilus hibernationus* HSX-25051 according to claim 1, characterized in that, The *Historhizium anisopliae* HSX-25051 carries pathogenicity associated with *Historhizium anisopliae*. luxS Gene.

3. The *Histophilus hibernationus* HSX-25051 according to claim 1, characterized in that, The aforementioned Histotrophozoites HSX-25051 can cause one or more clinical manifestations, including depression, somnolence, and abnormal breathing, as well as histopathological changes in one or more organs, such as the lungs, spleen, and liver.

4. The application of the histophilic bacteria HSX-25051 as described in claim 1 in etiological research.

5. The application of the histophilic bacteria HSX-25051 according to claim 4 in etiological research, characterized in that, The etiological studies include the construction of animal models of bovine Histophilus sleep infection, research on the pathogenic mechanism of Histophilus sleep, or research on the host infection process.